SEC 13F Intelligence

CHECKPOINT THERAPEUTICS INC

CUSIP 162828107

Checkpoint Therapeutics Inc has 49 institutional holders in Filings Flow’s 13F database, together reporting 5.79M shares worth $369M as of Q4 2021. The largest reported holders are Spotlight Asset Group, Inc., Citadel Advisors LLC, and Susquehanna International Group, LLP.

Institutional Holders
49
Q4 2021
Reported Value
$369M
Ticker
unmapped
private placement or foreign
Quarters Tracked
6

Ownership Trend

Institutional holders
Q4 ’18: 11Q4 ’18Q1 ’19: 14Q1 ’19Q2 ’19: 26Q2 ’19Q3 ’19: 23Q3 ’19Q2 ’21: 58Q2 ’21Q4 ’21: 49Q4 ’21filingsflow.com
Total reported value
Q4 ’18: $1MQ4 ’18Q1 ’19: $2MQ1 ’19Q2 ’19: $3MQ2 ’19Q3 ’19: $5MQ3 ’19Q2 ’21: $96MQ2 ’21Q4 ’21: $369MQ4 ’21filingsflow.com

Holders

Mixed quarters
Export to Excel
Manager% of PortfolioValueSharesQuarter
Spotlight Asset Group, Inc.$143M AUM0.62%$622,000661.6KQ1 2023
CITADEL ADVISORS LLC$618.5B AUM0.00%$263,000252.9KQ3 2022OLDER
SUSQUEHANNA INTERNATIONAL GROUP, LLP$893.3B AUM0.00%$24,00022.8KQ3 2022OLDER
HAP Trading, LLC$1.1B AUM—$012.8KQ3 2022OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.